Summary.-Mouse myeloma cells (MPC-ll) secreting gamma-2-b globulin were shown to proliferate into solid tumours after transplantation into the hamster cheek pouch. The implanted tumours continued to grow during the first 2 weeks; thereafter they diminished in size and disappeared completely a month after transplantation. The specific MPC-11 gammaglobulin could be detected in the serum of the hosts within 2 days after the transplantation and the changes in its concentration roughly correlated with the tumour size. The estimated half-life of the MPC-1l gammaglobulin in the circulation of the tumour-bearing hamsters was 4-6 days. Host resistance was demonstrated in tumour-bearing hamsters by their failure to develop tumours on second challenge with MPC-ll cells.
THE HAMSTER cheek pouch is known to be a " privileged site " for homo-and heterotransplants. Hamster skin grafts have been reported to survive for long periods in cheek pouches of untreated animals (Billingham, Ferrigan and Silvers, 1960) , while some human cancers grow well for periods ranging between 3 and 52 weeks in cheek pouches of hamsters treated with cortisone (Patterson, 1968) . Sensitized rabbit lymphocytes can proliferate, differentiate into plasma cells and synthesize species specific globulin upon restimulation with the proper antigen and transfer to the hamster's cheek pouch (Zlotnick, 1963) . Recently, mouse plasmacytoma cells transferred into the hamster's cheek pouch have been shown to proliferate and form solid tumours which produce their characteristic paraprotein. This paraprotein could be demonstrated both in situ and in the sera of the hosts (Zlotnick and Slavin, 1972) .
The implanted mouse plasma cell tumour in the hamster's cheek pouch could present an experimental model for the study not only of tumour biology, but also of the effects of the continued presence of a foreign protein in the circulation of an immunologically competent host. The present report describes the changes in tumour size and in the concentration of mouse gammaglobulin in the hamster serum following implantation of mouse plasmacytoma cells in the cheek pouch. It is also shown that mouse plasmacytoma cells transplanted into the cheek pouch are capable of sensitizing recipient hamsters, which become resistant to subsequent inoculations with the same tumour cells.
MATERIALS AND METHODS
Tumour.-The Marwin plasma cell-1 (MPC-11) mouse tumour, secreting gamma 2-b globulin, was originally induced in Balb/c mice by Dr John Fahey. The tumour specimen, provided by Dr Reuven Laskov, was derived from an established culture cell line (Laskov and Scharff, 1970) and has been maintained in our laboratory by serial passages in Balb/c mice.
This work wvas suipporte(l in part by a grant from the Judith Segal Memorial Fund. Implantation procedure into the hamster's cheek pouch.-MPC-i1 tumours were removed from the mouse, cut into small pieces and teased in phosphate buffered saline (PBS), pH 7-6. After allowing the tissue fragments to settle, the cells were recovered from the supernatant by centrifugation at 1000 rev/ min and washed once in PBS. A total of 2 x 107 cells in a volume of 0i15-0{25 ml were injected into each cheek pouch of Syrian hamsters (Hebrew University strain) weighing 80-100 g. The hamsters were examined at 4-7 day intervals; the size of the tumours in the cheek pouches was established by measuring their largest diameter, and 1 ml of blood was withdrawn from the eye for subsequent quantitation of the paraprotein in the serum. All manipulations were cariied out under ether anaesthesia.
Preparation of rabbit anti-MPC-II globulin serum.-MPC-il gammaglobulin was purified from ascites fluid of tumour-bearing Balb/c mice by ammonium sulphate precipitation followed by column chromatography (DEAE cellulose), as already described (Zlotnick and Slavin, 1972) . Anti-MPC-il serum was prepared by immunization of rabbits with purified MPC-i 1 gamma 2-b globulin incorporated in Freund's complete adjuvant. The specificity of the obtained antisera was established in a previous publication (Zlotnick and Slavin, 1972) . (Mancini, Carbonara and Heremans, 1965 Some of the tumours which reached a diameter of 5 mm after 4 days had disappeared a week after implantation. Most tumours, however, showed a linear growth and reached 5-10 mm after 4 days, 7-20 mm after 8 days, and up to 35 mm 14 days after transplantation (Fig. 1) . These tumours were surrounded by a viscous mucus. During the first 8-10 days the transplants had a firm consistency and a healthy pink appearance (Fig. 2) . Histologically, the areolar tissue of the cheek pouch was replaced by mononuclear cells. The cell masses were divided by fine septa in which capillaries and larger DAYS AFTER TRANSPLANTATION vessels were seen (Fig. 3) . From the 14th day on, all tumours declined in size and disappeared completely towards the end of the 4th week after inoculation. Histology of the tumours from the 14th day on revealed either areas of central necrosis or fibrosis (Fig. 4) . After 5 weeks the cheek pouches regained their normal appearance.
Secretion of MPC-11 gammaglobulin (paraprotein) into the serum of the host The mouse MPC-11 globulin was quantitated in the sera of the tumourbearing hamsters and Balb/c mice. The MPC-11 globulin could be detected by Ouchterlony's technique in the sera of the tumour-bearing hamsters by the third day after inoculation of the tumour cells; its concentration increased to peak values (2-14 mg/ml) 10 days after transplantation. Thereafter it declined and dropped to less than 0-2 mg/ml 30 days after transplantation. In some hamsters the rate of increase in the MPC-11 globulin concentration in the serum was slower and reached peak values only 2 weeks following inoculation (Fig. 5) . In general there was a correlation between the size of the tumours in the hamsters' cheek pouches and the amount of MPC-11 globulin in their sera (Fig. 6 ). This correlation was maintained during the first 10 days after the transplantation. However, while the growth of the tumours was linear, the serum paraprotein concentration increased after a lag period of 3-5 days (Fig. 5) . Fig. 7 compares the concentration of the MPC-11 globulin in sera of tumourbearing mice and hamsters. During the first 10 days following transplantation there was an increase in the paraprotein concentration in the sera, which was similar in both species. Thereafter, the amount of the paraprotein in the sera of the Balb/c mice continued to increase whereas that in the hamsters declined, as described above. The observations on Balb/c tumour-bearing mice could not be prolonged beyond 4 weeks because of the high mortality of the animals. Estimated life span of MPC-11 paraprotein in the circulation of the hamnster The rate of decline in the level of mouse MPC-1 1 globulin in the sera differed among the individual tumour-bearing hamsters. In general, hamsters with higher peak levels of paraprotein in the serum had higher rates of paraprotein elimination (Fig. 5) . This observation has already been reported in tumourbearing Balb/c mice (Humphrey and Fahey, 1961) and in humans (Waldmann, 1969) . The correlation, however, was not absolute, so that it is not clear whether a simple gross increase in mouse gammaglobulin level was entirely responsible for its increased elimination.
In order to determine the turnover of the mouse paraprotein in the circulation of the heterologous host, the tumours were excised from the cheek pouches of 10 animals 10-12 days after inoculation. The changes in paraprotein concentrations in the sera of 2 of these animals during the days following the excision of the tumours are shown in Fig. 8 . The rate of decline in the MPC-11 globulin levels suggested a T/2 of 4-6 days. This value is similar to the rate of MPC-1 1 gammaglobulin elimination from the sera of normal Balb/c mice (T/2 4-9 days) reported by Humphrey and Fahey (1961) .
The rate of decline in MPC-II globulin concentration during spontaneous regression of the tumours from the cheek pouches was similar to that in animals after excision of the tumours (Fig. 8) . This finding suggests that gammaglobulin secretion by the plasmacytomata had ceased 10-12 days after implantation.
Host resistance
In order to test for development of resistance to the implanted tumours, hamsters which had been inoculated with MPC-11 cells were challenged again with the same cells after regression of the tumours produced by the first inoculation. In keeping with previous observations, solid tumours developed in 17 of the 20 hamsters inoculated for the first time. Seven days after injection, the size of the tumours ranged between 7 and 20 mm, and the concentration of the MPC-1i gammaglobulin in the serum was between 0 44 and 1l10 mg/ml. Six weeks after the first challenge the tumours had regressed completely, the cheek pouch appeared While the growth of the tumours was linear, the serum paraprotein concentration increased after a lag period of [3] [4] [5] days. This finding suggests that transplanted MPC-11 cells passed through a stage of multiplication, followed by a stage of differentiation with gammaglobulin secretion. The growth kinetics of the transplanted tumours appeared to be different from those of MPC-11 cells cultured in vitro, in which a linear increase in gammaglobulin secretion has been shown to occur after a lag period of minutes only (Scharff, Shapiro and Ginsberg, 1967) .
Grafts in the hamster's cheek pouch are believed to be incapable of sensitizing their hosts (Billingham et al., 1960; Patterson, 1968) . However, hamsters which had developed solid tumours following injection of MPC-11 cells in the cheek pouch, appeared 6 weeks later to be resistant to a second challenge with the same tumour cells. This finding suggests that the regression of the tumours which had started 10-14 days after inoculation into the cheek pouch could have been related to an immunological host response. Preliminary experiments have shown that MPC-11 cells proliferate into solid tumours also after transplantation into the cheek pouches of hamsters which had been immunized against purified MPC-1 paraprotein. Thus, humoral antibodies against the mouse gammaglobulin do not seem to be involved in the rejection of the implanted tumours. The nature of the host response to the MPC-11 tumours is currently being investigated in this laboratory.
